Issue Information
8 August 2021
Issue Information
8 August 2021
Two Faces of Pioglitazone: Sorting Out the Roles of its PPARγ Binding Versus Mitochondrial Pyruvate Carrier Inhibition Is Not So Simple
Liyun Yuan, Kyle S. McCommis, Brent A. Neuschwander‐Tetri – 8 August 2021
Breastfeeding to Prevent NAFLD
George Boon‐Bee Goh, Wah Kheong Chan, Vincent Wai‐Sun Wong – 8 August 2021
Issue Information ‐ Author Checklist
8 August 2021
Liver Transplantation for Acute Liver Injury in Asians Is More Likely Due to Herbal and Dietary Supplements
Varun Kesar, Lindsey Channen, Umair Masood, Priya Grewal, Jawad Ahmad, Nitzan C. Roth, Joseph A. Odin – 8 August 2021 – Drug‐induced liver injury (DILI) due to medications and herbal and dietary supplements (HDSs) is a major cause of acute liver injury leading to liver transplantation (LT). This study used United Network for Organ Sharing LT data to analyze severe HDS‐induced acute liver injury in the United States.
Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
Hae Lim Lee, Sung Won Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Ho Joong Choi, Gun Hyung Na, Young Kyoung You, Il Young Park, Dong Goo Kim – 8 August 2021 – The anticancer effect of statins is drawing attention. However, it is unclear whether statin use reduces the risk of hepatocellular carcinoma (HCC) recurrence in patients who undergo liver transplantation (LT) for HCC. Consecutive patients who underwent LT for HCC between 1995 and 2019 were enrolled.
Issue Information
8 August 2021
Letter to the Editor: Saroglitazar for Treatment of NAFLD and NASH
Karan Kumar, Anand Kulkarni, Rakesh Kumar Jagdish – 7 August 2021